Atlas Trials

A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis

Clinical trial NCT07091357 · RECRUITING

Trial details

NCT number
NCT07091357
Sponsor
Guangdong Hengrui Pharmaceutical Co., Ltd
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Seasonal Allergic Rhinitis
Start date
2025-08-06
Primary completion
2025-10-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.